Scientists are rapidly investigating retatrutide, a innovative treatment from Eli Lilly, as a potential breakthrough in body reduction . Unlike many earlier approaches, retatrutide is a double -action compound targeting simultaneously GLP-1 and GIP, substances that affect satiety and glucose reg… Read More